Neuroblastoma
-
Nanoengineering may hold the key to developing more effective, safer treatments for a deadly childhood cancer
A grant from the National Institutes of Health will allow John T. Wilson to explore ways to use recently developed nanoparticles to stimulate immunity pathways in children, with the aim of making immunotherapy treatments for neuroblastoma more effective. Read MoreSep 16, 2022
-
A new target for neuroblastoma
Vanderbilt investigators have discovered that a sirtuin protein has oncogenic properties in neuroblastoma cells — and that blocking it reduces their growth and tumor-like characteristics. Read MoreFeb 14, 2018
-
Blocking neuroblastoma cell growth
An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read MoreMar 22, 2017
-
Proliferative capacity of neuroblastoma
The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma. Read MoreAug 31, 2016
-
Origins of neuroblastoma
Vanderbilt researchers are exploring how neuroblastoma tumors begin and progress, knowledge that could provide new treatments for this pediatric cancer. Read MoreAug 12, 2015
-
Grant to support neuroblastoma research
The Rally Foundation awarded an $80,000 grant to the Monroe Carell Jr. Children’s Hospital at Vanderbilt to fund a research study on the treatment of neuroblastoma. Read MoreJun 24, 2011